These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16534091)

  • 1. Managing low-grade cervical lesions.
    Howlett R; Bryson P; Mai V; McLachlin M
    CMAJ; 2006 Mar; 174(6):813; author reply 813-4. PubMed ID: 16534091
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing Minimally Abnormal Cervical Cancer Screening Test Results.
    Sawaya GF; Lamar R; Perkins RB
    JAMA; 2020 Oct; 324(15):1557-1558. PubMed ID: 32975557
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of low-grade cervical lesions in young women.
    Lau S; Franco EL
    CMAJ; 2005 Sep; 173(7):771-4. PubMed ID: 16186584
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing low-grade cervical lesions.
    Burn R
    CMAJ; 2006 Mar; 174(6):813; author reply 813-4. PubMed ID: 16534090
    [No Abstract]   [Full Text] [Related]  

  • 5. [HIV, HPV and cervical pathology].
    Quéreux C; Bory JP
    Contracept Fertil Sex; 1997 Feb; 25(2):120-4. PubMed ID: 9116771
    [No Abstract]   [Full Text] [Related]  

  • 6. Practice Bulletin No. 140: management of abnormal cervical cancer screening test results and cervical cancer precursors.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2013 Dec; 122(6):1338-67. PubMed ID: 24264713
    [No Abstract]   [Full Text] [Related]  

  • 7. Cervical cancer guidelines. Clinical practice guidelines in oncology.
    Teng N; Abu-Rustum NR; Bahador A; Bookman MA; Bristow RE; Campos S; Cho KR; Copeland L; Eifel P; Fiorica J; Greer BE; Kapp DS; Kavanagh J; Koh WJ; Kuettel M; Lurain JR; Molpus KL; Nag S; Partridge EE; Powell CB; Reynolds RK; Small W; Soper J; Tillmanns TD;
    J Natl Compr Canc Netw; 2004 Nov; 2(6):612-30. PubMed ID: 19780304
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing cervical cancer globally by acting locally: if not now, when?
    Gage JC; Castle PE
    J Natl Cancer Inst; 2010 Oct; 102(20):1524-7. PubMed ID: 20884892
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of cervical dysplasia with colposcopy in Finland].
    Zilliacus R; Nieminen P
    Duodecim; 2003; 119(1):50-5. PubMed ID: 12607472
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical question: ask the expert.
    Julian TM; Spitzer M; Twiggs L
    J Low Genit Tract Dis; 2007 Apr; 11(2):122. PubMed ID: 17415119
    [No Abstract]   [Full Text] [Related]  

  • 11. HPV & age-appropriate cervical cancer prevention for adolescents.
    Kostas-Polston EA; Johnson-Mallard V; Berman NR
    Nurse Pract; 2012 Jun; 37(6):30-8. PubMed ID: 22546780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and clinical management of cervical HPV infections].
    Carcopino X; Camus C; Halfon P
    Presse Med; 2015; 44(7-8):716-26. PubMed ID: 26067573
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer screening in the young female.
    Kaufman RH
    Arch Pathol Lab Med; 2011 Mar; 135(3):296-7. PubMed ID: 21366450
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preinvasive lesions in gynaecology - uterine cervix].
    Mouková L; Feranec R; Chovanec J
    Klin Onkol; 2013; 26 Suppl():S49-51. PubMed ID: 24325165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening clinical practice guidelines in oncology.
    Partridge EE; Abu-Rustum NR; Campos S; Edelson M; Fahey PJ; Fiorica J; Greer BE; Lieberman RW; Likes W; Molpus KL; Nava ME; Reynolds RK; Singh DK; Smith-McCune K; Soper J; Teng N; Trimble CL; Wilczynski S;
    J Natl Compr Canc Netw; 2004 Nov; 2(6):570-87. PubMed ID: 19780301
    [No Abstract]   [Full Text] [Related]  

  • 16. [Summary of interdisciplinary Professional Society of Gynecological Oncology guidelines for diagnosis and therapy of cervix carcinoma].
    Zentralbl Gynakol; 2001 May; 123(5):292-8. PubMed ID: 11452957
    [No Abstract]   [Full Text] [Related]  

  • 17. Cervical cancer screening and updated Pap guidelines.
    Warren JB; Gullett H; King VJ
    Prim Care; 2009 Mar; 36(1):131-49, ix. PubMed ID: 19231606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory management of cervical intraepithelial neoplasia: proposing a new paradigm.
    Herfs M; Crum CP
    Adv Anat Pathol; 2013 Mar; 20(2):86-94. PubMed ID: 23399794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of HPV-HR DNA testing during the follow-up after treatment of CIN3/AIS.
    Banović M; Mahovlić V; Salopek KM; Banović V; Babić I; Orešković S; Babić D
    Pathol Oncol Res; 2015 Jul; 21(3):613-7. PubMed ID: 25432549
    [No Abstract]   [Full Text] [Related]  

  • 20. HPV16 and increased risk of recurrence after treatment for CIN.
    Kafali H
    Gynecol Oncol; 2008 May; 109(2):309-10; author reply 310-1. PubMed ID: 18289651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.